Biocompatibility and Surface Characteristics of Resin-Modified Glass Ionomer Cements with Ammonium Quaternary Compounds or Silver Nanoparticles: An In Vitro Study
Table 4
Cell viability percentages by MTT assay for GC Fuji PLUS modifications.
Groups
Mean
SD
Maximum
Minimum
MEM control
100
0
100
100
GC Fuji PLUS
9.83
0.17
10
9.62
GC Fuji PLUS + hexadecyltrimethylammonium bromide 1%
9.75
0.38
10
9.25
GC Fuji PLUS + hexadecyltrimethylammonium bromide 2%
10.83
0.62
11.25
10
GC Fuji PLUS + benzalkonium chloride 1%
9.46
0.60
10.12
8.75
GC Fuji PLUS + benzalkonium chloride 2%
10.38
0.76
11.25
9.5
GC Fuji PLUS + cetylpyridinium chloride 1%
9.79
0.31
10
9.37
GC Fuji PLUS + cetylpyridinium chloride 2%
11.25
0.00
11.25
11.25
GC Fuji PLUS LC + silver nanoparticles 1%
10.17
0.82
11.25
9.5
GC Fuji PLUS + silver nanoparticles 2%
12.33
1.63
14.12
10.37
SD: standard deviation; MTT assay: 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl-tetrazolium bromide assay. Statistically significant differences between GC Fuji PLUS and the experimental group.
